医疗机构报告了强的2026年第三季度收益,3.4亿美元的诺克特里克斯收购和2.62亿美元股东回报. ResMed reports strong Q3 2026 earnings, $340M Noctrix acquisition, and $262M shareholder returns.

医疗机构报告了强的2026年第三季度财务业绩,收入达到143亿美元,净利增长 20%. ResMed reported strong Q3 2026 financial results, with revenue reaching $1.43 billion and net income rising 20%. 该公司获得了5.2亿美元的自由现金流,并通过回购和股息向股东返还2.62亿美元. The company generated $520 million in free cash flow and returned $262 million to shareholders via buybacks and dividends. 此外,ResMed 签署了一项价值3.4亿美元的收购诺克特里克斯健康协议,预计将于2026年6月完成. Additionally, ResMed signed a $340 million deal to acquire Noctrix Health, expected to close in June 2026.